Comment on high HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy

European Journal of Clinical Investigation

Volumn 39, Issue 6, 2009, Pages 533-

  Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE;

CHOLESTEROL BLOOD LEVEL; ENZYME ACTIVITY; HUMAN; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHOLESTEROL, HDL; FEMALE; GLUCOCORTICOIDS; HUMANS;

EID: 65549160571     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02142.x     Document Type: Letter

References (6)

1. García-Gómez C, Nolla JM, Valverde J, Nardáez J, Corbella E, Pintó X. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest 2008 38 : 686 92. (Pubitemid 350297184)
2. Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepsis AD et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective controlled study. Arthritis Res Ther 2006 8 : R82.
3. Dullaart RPF, Dallinga-Thie GM, Wolffenbuttel BHR, Van Tol A. CETP inhibition in cardiovascular risk management: a critical appraisal. Eur J Clin Invest 2007 37 : 90 8. (Pubitemid 46066487)
4. Beentjes JA, Van Tol A, Sluiter WJ, Dullaart RPF. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy. Scand J Clin Lab Invest 2000 60 : 189 98. (Pubitemid 30399104)
5. Dullaart RPF, Schols JL, Van Der Steege G, Zelissen PMJ, Sluiter WJ, Van Beek AP. Glucocorticoid replacement is associated with hypertriglyceridemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary adults. Clin Endocrinol (Oxf) 2008 69 : 359 66.
6. Filipsson H, Monson JP, Koltowska-Häggström M, Mattson A, Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 2006 91 : 3954 61. (Pubitemid 44536870)